Gossamer Bio Inc (GOSS)
0.8793
-0.01
(-0.79%)
USD |
NASDAQ |
Nov 05, 16:00
0.8793
0.00 (0.00%)
After-Hours: 16:00
Gossamer Bio Profit Margin (Quarterly): 51.37% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 51.37% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
51.37%
Minimum
Jun 2024
51.37%
Maximum
Jun 2024
51.37%
Average
51.37%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Bioxytran Inc | -- |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Operating Margin (Quarterly) | 54.35% |